Document is current

Any future updates will be listed below

Co-targeting the HER and IGF/insulin receptor axis in breast cancer, with triple targeting with endocrine therapy for hormone-sensitive disease

Crossref DOI link: https://doi.org/10.1007/s10549-017-4169-9

Published Online: 2017-02-24

Published Print: 2017-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark